Lamotrigine treatment reverses depressive-like behavior and alters BDNF levels in the brains of maternally deprived adult rats.

Article Details

Citation

Abelaira HM, Reus GZ, Ribeiro KF, Zappellini G, Cipriano AL, Scaini G, Streck EL, Quevedo J

Lamotrigine treatment reverses depressive-like behavior and alters BDNF levels in the brains of maternally deprived adult rats.

Pharmacol Biochem Behav. 2012 May;101(3):348-53. doi: 10.1016/j.pbb.2012.01.019. Epub 2012 Jan 27.

PubMed ID
22306746 [ View in PubMed
]
Abstract

Lamotrigine is an anticonvulsant and has an antiglutamatergic action, which may contribute to its antidepressant effects, since glutamate has been linked to depression. The purpose of the present study was to investigate the behavioral and molecular effects of lamotrigine treatment in maternally deprived rats. To this aim, deprived and non-deprived male rats were treated with lamotrigine (20 mg/kg) once a day for 14 days during their adult phase. Their behavior was then assessed in the forced swimming and open field tests. In addition to this, the BDNF and NGF levels were assessed in the prefrontal cortex, hippocampus and amygdala. In the course of this study we demonstrated that maternally deprived rats treated with saline and lamotrigine showed an increase in their immobility time and a decrease in the climbing and swimming times when compared with non-deprived rats treated with saline alone. Treatment with lamotrigine reversed the increase in the immobility time in the deprived rats. The BDNF levels were decreased in the amygdala in deprived rats treated with saline, and treatment with lamotrigine reversed this decrease. The NGF levels were decreased in the hippocampus in deprived rats treated with saline, but treatment with lamotrigine did not reverse this decrease. In conclusion, lamotrigine showed antidepressant effects in the forced swimming test, and it presented positive effects on the BDNF protein levels in the amygdala of maternally deprived rats.

DrugBank Data that Cites this Article

Drug Targets
DrugTargetKindOrganismPharmacological ActionActions
Lamotrigine5-hydroxytryptamine receptor 2AProteinHumans
Unknown
Inhibitor
Details
LamotrigineAcetylcholine receptor subunit alphaProteinHumans
Unknown
Inhibitor
Details
LamotrigineAdenosine receptor A1ProteinHumans
Unknown
Inhibitor
Details
LamotrigineAdenosine receptor A2aProteinHumans
Unknown
Inhibitor
Details
LamotrigineAlpha-1A adrenergic receptorProteinHumans
Unknown
Inhibitor
Details
LamotrigineAlpha-2A adrenergic receptorProteinHumans
Unknown
Inhibitor
Details
LamotrigineBeta-1 adrenergic receptorProteinHumans
Unknown
Inhibitor
Details
LamotrigineD(1) dopamine receptor (Protein Group)Protein groupHumans
Unknown
Inhibitor
Details
LamotrigineDopamine D2 receptorProteinHumans
Unknown
Agonist
Inhibitor
Details
LamotrigineGABA(A) Receptor (Protein Group)Protein groupHumans
Unknown
Antagonist
Inducer
Details
LamotrigineGABA(A) Receptor Benzodiazepine Binding Site (Protein Group)Protein groupHumans
Unknown
Inhibitor
Details
LamotrigineHistamine H1 receptorProteinHumans
Unknown
Antagonist
Details
LamotrigineKappa-type opioid receptorProteinHumans
Unknown
Inhibitor
Details